Skip to content

Alterations of immunologic mediators during severe sepsis

Alterations of immunologic mediators during severe sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN34508816
Enrollment
40
Registered
2006-06-13
Start date
2006-06-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe sepsis Infections and Infestations Sepsis

Interventions

Daily blood samples for 7 days

Sponsors

Urban Clinical Center of St Georg in Leipzig (Städt. Klinikum St. Georg, Leipzig) (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older 2. Agreement with study procedures, informed consent 3. Fulfilling 3 out of 4 criteria of a systemic inflammatory response syndrome (SIRS) 4. Suspected or proven infection 5. Two or more sepsis-induced organ dysfunctions 6. Start of first sepsis-induced organ dysfunction within the last 36 hours

Exclusion criteria

Exclusion criteria: 1. Non-agreement with study procedures 2. Sign of severe sepsis for more than 36 hours 3. Chronic immuno-compromizing diseases 4. Chronic therapy with anti-inflammatory drugs 5. Non-curable cancer diseases 6. Chronic renal failure with hemodialysis 7. Pregnant or breast feeding

Design outcomes

Primary

MeasureTime frame
Alterations of immunologic parameters

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026